SCHEMBL2500207

SCHEMBL2500207

COc1ccccc1C1(N[C@H](C(=O)N(C)C)c2ccccc2)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
IDO1 P14902 2/20 0.39
CBX7 O95931 1/20 0.38
CDYL Q9Y232 1/20 0.38
ALDH1A1 P00352 4/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
NPSR1 Q6W5P4 3/20 0.38
ACLY P53396 1/20 0.37
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ACHE P22303 2/20 0.36
GRIK1 P39086 1/20 0.36
CRHBP P24387 2/20 0.36
CRHR2 Q13324 2/20 0.36
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MDM2 Q00987 1/20 0.35
MEN1 O00255 1/20 0.35
KCNQ3 O43525 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2497477 0.87 KMT2A (0.42) KMT2AIDO1CBX7CDYLALDH1A1
SCHEMBL2492996 0.87 KMT2A (0.42) KMT2AIDO1CBX7CDYLALDH1A1
SCHEMBL2496302 0.86 KMT2A (0.41) KMT2AIDO1CBX7CDYLALDH1A1
SCHEMBL2496408 0.85 CBX7 (0.40) KMT2AIDO1CBX7CDYLALDH1A1
SCHEMBL2492829 0.85 KMT2A (0.40) KMT2AIDO1CBX7CDYLALDH1A1
SCHEMBL2492782 0.84 PYGL (0.44) KMT2ACBX7CDYL
SCHEMBL2498534 0.83 CBX7 (0.39) KMT2AIDO1CBX7CDYLNPSR1
SCHEMBL2501794 0.83 CBX7 (0.39) KMT2AIDO1CBX7CDYLMDM2
SCHEMBL2498800 0.83 CBX7 (0.38) KMT2AIDO1CBX7CDYLNPSR1
SCHEMBL2501749 0.82 KMT2A (0.43) KMT2AIDO1CBX7CDYLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 KMT2A 1662/4885IDO1 4/4885CBX7 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.